Cargando…
Acceptability of Multiparticulate Dosing Using Sympfiny(®) Delivery System with Children (Age 1–12)
This study investigated multiparticulate formulation administered over a two-week period of time via the Sympfiny(®) system with children of ages 1–12 years. The study was conducted with parent–child pairs (N = 120 total participants) following a specific dose strategy to mimic PURIXAN’s dosing guid...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698589/ https://www.ncbi.nlm.nih.gov/pubmed/36432715 http://dx.doi.org/10.3390/pharmaceutics14112524 |